University of Naples "Federico II"
Naples, 80100, Italy
NCT Number: NCT04546386
This study investigates the retinal vascular features, using optical coherence tomography angiography, in patients during one year's follow up after the endoscopic endonasal surgery to remove an intra-suprasellar pituitary adenoma compressing the optic nerve.
Looking for future studies?
Notify Me45 year–65 year
All sexes
Observational
Naples, 80100, Italy
The role of the optical coherence tomography angiography to detect the changes in retinal vascular networks in patients after 48 hours and 1 year from the endoscopic endonasal surgery to remove an intra-suprasellar pituitary adenoma compressing the optic nerve.
The optical coherence tomography angiography allows a detailed and quantitative analysis of the retinal vascular networks and to follow their changes over time.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter
Time frame: one year
To evaluate the changes in vessel density of the retinal vascular network 48 hours and 1 year after endoscopic endonasal pituitary surgery for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve, using optical coherence tomography angiography. The parameter analyzed by optical coherence tomography angiography was the vessel density of the retinal vascular network.
Federico II University
Other
Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery During One Year's Follow up, by Optical Coherence Tomography Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001452
Abnormalities, Multiple, Adrenal Gland Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02750371
Brain Diseases, Brain Neoplasms
Bordeaux, France
View Trial DetailsNCT07247526
Anxiety Disorders, Brain Diseases
Edirne, Turkey (Türkiye)
View Trial DetailsNCT06826170
Brain Diseases, Brain Neoplasms
Milan, Italy
View Trial Details